Clinical trial reportBreast (Edinburgh, Scotland)Published
Neoadjuvant nivolumab + palbociclib + anastrozole for oestrogen receptor-positive/human epidermal growth factor receptor 2-negative primary breast cancer: Results from CheckMate 7A8
Regional connection
Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source
- Institution
- Bristol Myers Squibb
- County
- Mercer County
Publication record
- Type
- Clinical trial report
- Venue
- Breast (Edinburgh, Scotland)
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Breast Neoplasms; Pneumonia; Piperazines; Pyridines; Receptors, Estrogen; Antineoplastic Combined Chemotherapy Protocols; Neoadjuvant Therapy; Female; Anastrozole; Nivolumab; Erb-b2 Receptor Tyrosine Kinases
- PubMed ID
- 37741273
- PubMed Central ID
- PMC10519837
- Open access
- Yes, open
- Added to directory
- Source checked